These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 17498256

  • 1. High aspartate to alanine aminotransferase ratio is an indicator of cirrhosis and poor outcome in patients with primary sclerosing cholangitis.
    Nyblom H, Nordlinder H, Olsson R.
    Liver Int; 2007 Jun; 27(5):694-9. PubMed ID: 17498256
    [Abstract] [Full Text] [Related]

  • 2. The AST/ALT ratio as an indicator of cirrhosis in patients with PBC.
    Nyblom H, Björnsson E, Simrén M, Aldenborg F, Almer S, Olsson R.
    Liver Int; 2006 Sep; 26(7):840-5. PubMed ID: 16911467
    [Abstract] [Full Text] [Related]

  • 3. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection.
    Sheth SG, Flamm SL, Gordon FD, Chopra S.
    Am J Gastroenterol; 1998 Jan; 93(1):44-8. PubMed ID: 9448172
    [Abstract] [Full Text] [Related]

  • 4. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
    Giannini E, Botta F, Testa E, Romagnoli P, Polegato S, Malfatti F, Fumagalli A, Chiarbonello B, Risso D, Testa R.
    Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
    [Abstract] [Full Text] [Related]

  • 5. Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C.
    Imperiale TF, Said AT, Cummings OW, Born LJ.
    Am J Gastroenterol; 2000 Sep; 95(9):2328-32. PubMed ID: 11007237
    [Abstract] [Full Text] [Related]

  • 6. Alanine aminotransferase/aspartate aminotransferase ratio reversal and prolonged prothrombin time: a specific indicator of hepatic cirrhosis.
    Siddiqi AI, Siddiqeh M, Mehmood A, Siddiqui AM.
    J Ayub Med Coll Abbottabad; 2007 Sep; 19(3):22-4. PubMed ID: 18444585
    [Abstract] [Full Text] [Related]

  • 7. High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking.
    Nyblom H, Berggren U, Balldin J, Olsson R.
    Alcohol Alcohol; 2004 Sep; 39(4):336-9. PubMed ID: 15208167
    [Abstract] [Full Text] [Related]

  • 8. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy.
    Verma S, Gunuwan B, Mendler M, Govindrajan S, Redeker A.
    Am J Gastroenterol; 2004 Aug; 99(8):1510-6. PubMed ID: 15307869
    [Abstract] [Full Text] [Related]

  • 9. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
    Vardar R, Vardar E, Demiri S, Sayhan SE, Bayol U, Yildiz C, Postaci H.
    Hepatogastroenterology; 2009 Aug; 56(94-95):1459-65. PubMed ID: 19950810
    [Abstract] [Full Text] [Related]

  • 10. [Plasma levels of folate and vitamin B(12) in patients with chronic liver disease].
    Muro N, Bujanda L, Sarasqueta C, Gil I, Hijona E, Cosme A, Arenas J, Elosegui ME, Sarasola M, Calpasoro J, Arenas JI.
    Gastroenterol Hepatol; 2010 Apr; 33(4):280-7. PubMed ID: 20206409
    [Abstract] [Full Text] [Related]

  • 11. ASAT/ALAT ratio provides prognostic information independently of Child-Pugh class, gender and age in non-alcoholic cirrhosis.
    Haukeland JW, Schreiner LT, Lorgen I, Frigstad SO, Bang C, Raknerud N, Konopski Z.
    Scand J Gastroenterol; 2008 Apr; 43(10):1241-8. PubMed ID: 18609128
    [Abstract] [Full Text] [Related]

  • 12. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P, Fabris C, Bitetto D, Falleti E, Avellini C, Rossi E, Smirne C, Minisini R, Pirisi M.
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [Abstract] [Full Text] [Related]

  • 13. Primary sclerosing cholangitis: role of extrahepatic biliary resection.
    Pawlik TM, Olbrecht VA, Pitt HA, Gleisner AL, Choti MA, Schulick RD, Cameron JL.
    J Am Coll Surg; 2008 May; 206(5):822-30; discussion 830-2. PubMed ID: 18471705
    [Abstract] [Full Text] [Related]

  • 14. De Ritis ratio as diagnostic marker of alcoholic liver disease.
    Majhi S, Baral N, Lamsal M, Mehta KD.
    Nepal Med Coll J; 2006 Mar; 8(1):40-2. PubMed ID: 16827089
    [Abstract] [Full Text] [Related]

  • 15. Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic.
    Davies YK, Cox KM, Abdullah BA, Safta A, Terry AB, Cox KL.
    J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):61-7. PubMed ID: 18607270
    [Abstract] [Full Text] [Related]

  • 16. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K, Wawrzynowicz-Syczewska M, Boroń-Kaczmarska A, Sych Z.
    Med Sci Monit; 2001 Jul; 7(5):962-5. PubMed ID: 11535942
    [Abstract] [Full Text] [Related]

  • 17. Effects of intermittent Pringle's manoeuvre on cirrhotic compared with normal liver.
    Sugiyama Y, Ishizaki Y, Imamura H, Sugo H, Yoshimoto J, Kawasaki S.
    Br J Surg; 2010 Jul; 97(7):1062-9. PubMed ID: 20632273
    [Abstract] [Full Text] [Related]

  • 18. Characterization of liver enzymes on living related liver transplantation patients with acute rejection.
    Chiu KW, Chen YS, de Villa VH, Wang CC, Eng HL, Wang SH, Liu PP, Jawan B, Huang TL, Cheng YF, Chen CL.
    Hepatogastroenterology; 2005 Jul; 52(66):1825-7. PubMed ID: 16334785
    [Abstract] [Full Text] [Related]

  • 19. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group.
    Okolicsanyi L, Fabris L, Viaggi S, Carulli N, Podda M, Ricci G.
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):685-91. PubMed ID: 8853259
    [Abstract] [Full Text] [Related]

  • 20. Hyaluronic acid and aspartate aminotransferase levels normalized by liver function can reflect sinusoidal impairment in chronic liver disease.
    Testa E, Malfatti F, Milazzo S, Cordiviola C, Cotellessa T, Marabotto E, Giannini E, Ceppa P, Mamone M, Risso D, Testa R.
    Liver Int; 2006 May; 26(4):439-44. PubMed ID: 16629647
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.